Trials / Completed
CompletedNCT01417754
Changes in Breast 3D Ultrasound Measurements Using Toremifene
Volume and Circulation Changes of The Breast in 3D Ultrasound During Toremifene Versus Nonmedicated Menstrual Cycle
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Satakunta Central Hospital · Academic / Other
- Sex
- Female
- Age
- 25 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To investigate if there are detectable changes in volume and circulation in breasts of healthy volunteers using toremifene 20 mg in luteal phase of the menstruation cycle versus nonmedicated cycle.
Detailed description
20 women were participated to this trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Toremifene | 20mg toremifene per day in tablet form starting from the cycle day 15 and continued to premenstrual period. Medication using about 10 days per volunteer |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2010-11-01
- Completion
- 2011-06-01
- First posted
- 2011-08-16
- Last updated
- 2011-08-23
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01417754. Inclusion in this directory is not an endorsement.